|
1
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ali HA Ahmed, Di J, Mei W, Zhang YC, Li Y,
Du ZW and Zhang GZ: Antitumor activity of lentivirus-mediated
interleukin-12 gene modified dendritic cells in human lung cancer
in vitro. Asian Pac J Cancer Prev. 15:611–616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Das D, Preet R, Mohapatra P, Satapathy SR
and Kundu CN: 1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the
inhibitory effect of resveratrol on 5-fluorouracil
sensitive/resistant colon cancer cells. World J Gastroenterol.
19:7374–7388. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chermann JC, Raynaud M, Jasmin C and Mathé
G: Powerful new inhibitor of murine leukaemia and sarcoma viruses.
Nature. 227:173–174. 1970. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu J, Mei WJ, Xu AW, Tan CP, Shi S and Ji
LN: Synthesis, characterization and antiviral activity against
influenza virus of a series of novel manganese-substituted rare
earth borotungstates heteropolyoxometalates. Antiviral Res.
62:65–71. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Feng CG, Xiong YD and Liu X: Synthesis,
spectroscopy and antibacterial activity of supermolecular compounds
of organotitanium substituted heteropolytungstates containing
8-quinolinol. Guang Pu Xue Yu Guang Pu Fen Xi. 31:1153–1160.
2011.PubMed/NCBI
|
|
7
|
Matsumoto Y and Komiyama M: DNA hydrolysis
by rare-earth metal ions. Nucleic Acids Symp Ser. 27:33–34.
1992.
|
|
8
|
Matsumura K and Komiyama M: Enormously
fast RNA hydrolysis by lanthanide (III) ions under physiological
conditions: Eminent candidates for novel tools of biotechnology. J
Biochem. 122:387–394. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Palasz A and Czekaj P: Toxicological and
cytophysiological aspects of lanthanides action. Acta Biochim Pol.
47:1107–1114. 2000.PubMed/NCBI
|
|
10
|
Sato T, Hashizume M, Hotta Y and Okahata
Y: Morphology and proliferation of B16 melanoma cells in the
presence of lanthanoid and Al3+ions. Biometals. 11:107–112. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McGahon AJ, Martin SJ, Bissonnette RP,
Mahboubi A, Shi Y, Mogil RJ, Nishioka WK and Green DR: The end of
the (cell) line: Methods for the study of apoptosis in vitro.
Methods Cell Biol. 46:153–185. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen H, Takahashi S, Imamura M, Okutani E,
Zhang ZG, Chayama K and Chen BA: Earthworm fibrinolytic enzyme:
Anti-tumor activity on human hepatoma cells in vitro and in vivo.
Chin Med J (Engl). 120:898–904. 2007.PubMed/NCBI
|
|
13
|
Ribble D, Goldstein NB, Norris DA and
Shellman YG: A simple technique for quantifying apoptosis in
96-well plates. BMC Biotechnol. 5:122005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lambert KE, Huang H, Mythreye K and Blobe
GC: The type III transforming growth factor-beta receptor inhibits
proliferation, migration and adhesion in human myeloma cells. Mol
Biol Cell. 22:1463–1472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou J, Wang LF, Wang JY and Tang N:
Synthesis, characterization, antioxidative and antitumor activities
of solid quercetin rare earth (III) complexes. Mol Biol Cell.
83:41–48. 2001.
|
|
16
|
Martin SJ and Green DR: Apoptosis and
cancer: The failure of controls on cell death and cell survival.
Crit Rev Oncol Hematol. 18:137–153. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reed JC: Apoptosis-targeted therapies for
cancer. Cancer Cell. 3:17–22. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Delbridge AR and Strasser A: The BCL-2
protein family, BH3-mimetics and cancer therapy. Cell Death Differ.
22:1071–1080. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang J, Sun C, Wang S, He Q and Li D:
microRNA miR-10b inhibition reduces cell proliferation and promotes
apoptosis in non-small cell lung cancer (NSCLC) cells. Mol Biosyst.
11:2051–2059. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng G, Wang W, Chai K, Yang S, Li F and
Jiang K: Combination treatment with triptolide and
hydroxycamptothecin synergistically enhances apoptosis in A549 lung
adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt
signaling pathways. Int J Oncol. 46:1007–1017. 2015.PubMed/NCBI
|
|
21
|
Yang Y, Zhao Y, Ai X, Cheng B and Lu S:
Formononetin suppresses the proliferation of human non-small cell
lung cancer through induction of cell cycle arrest and apoptosis.
Int J Clin Exp Pathol. 7:8453–8461. 2014.PubMed/NCBI
|
|
22
|
Zou Y, Qin X, Xiong H, Zhu F, Chen T and
Wu H: Apoptosis of human non-small-cell lung cancer A549 cells
triggered by evodiamine through MTDH-dependent signaling pathway.
Tumour Biol. 36:5187–5193. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen Y, Meng L, Sun H, Zhu Y and Liu H:
Cochinchina momordica seed suppresses proliferation and metastasis
in human lung cancer cells by regulating multiple molecular
targets. Am J Chin Med. 43:149–166. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhivotovsky B: Caspases: The enzymes of
death. Essays Biochem. 39:25–40. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nair R, Roden DL, Teo WS, McFarland A,
Junankar S, Ye S, Nguyen A, Yang J, Nikolic I, Hui M, et al: c-Myc
and Her2 cooperate to drive a stem-like phenotype with poor
prognosis in breast cancer. Oncogene. 33:3992–4002. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hartl M and Bister K: Analyzing Myc in
cell transformation and evolution. Methods Mol Biol. 1012:21–49.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ren Y, Han X, Yu K, Sun S, Zhen L, Li Z
and Wang S: microRNA-200c downregulates XIAP expression to suppress
proliferation and promote apoptosis of triple-negative breast
cancer cells. Mol Med Rep. 10:315–321. 2014.PubMed/NCBI
|
|
28
|
Yang E, Zha J, Jockel J, Boise LH,
Thompson CB and Korsmeyer SJ: Bad, a heterodimeric partner for
Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell.
80:285–291. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu W, Wan OW and Chung KK: S-nitrosylation
of XIAP at Cys 213 of BIR2 domain impairs XIAP's anti-caspase 3
activity and anti-apoptotic function. Apoptosis. 20:491–499. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu X, Wen H, Hu Y, Yu H, Zhang Y, Chen C
and Pan X: STAT1-caspase 3 pathway in the apoptotic process
associated with steroid-induced necrosis of the femoral head. J Mol
Histol. 45:473–485. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Agarwal E, Chaudhuri A, Leiphrakpam PD,
Haferbier KL, Brattain MG and Chowdhury S: Akt inhibitor MK-2206
promotes anti-tumor activity and cell death by modulation of AIF
and Ezrin in colorectal cancer. BMC Cancer. 14:1452014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ukp Subramanian V, Nicholas AP, Thompson
PR and Ferretti P: Modulation of calcium-induced cell death in
human neural stem cells by the novel peptidylarginine deiminase-AIF
pathway. Biochim Biophys Acta. 1843:1162–1171. 2014. View Article : Google Scholar : PubMed/NCBI
|
